Drugs / Lenalidamide
last change Feb 2009 re-read 3 minutes ago

Lenalidamide

Developed for
complex regional pain syndrome type 1
Investigated by
Elgene Chemical · Mayo Clinic

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00166452 Jul 2005 → Apr 2007 complex regional pain syndrome type 1 Mayo Clinic Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lenalidamide ClinicalTrials.gov intervention name — accepted as the source's own label NCT00166452 ↗